Loading…

Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic

Summary Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin‐resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, select...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 1999-09, Vol.16 (9), p.767-771
Main Authors: Tentolouris, N., Jude, E. B., Smirnof, I., Knowles, E. A., Boulton, A. J. M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3
cites cdi_FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3
container_end_page 771
container_issue 9
container_start_page 767
container_title Diabetic medicine
container_volume 16
creator Tentolouris, N.
Jude, E. B.
Smirnof, I.
Knowles, E. A.
Boulton, A. J. M.
description Summary Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin‐resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, selected from an outpatient diabetic foot clinic. Seventy‐five patients (79 ulcers) with positive wound swabs were included. Size of ulcer and time to healing, in particular for MRSA‐infected ulcers, were measured in all patients. Results Gram‐positive aerobic bacteria were the commonest micro‐organism isolated (56.7%) followed by Gram‐negative aerobic bacteria and anaerobes (29.8% and 13.5%, respectively). Of the Gram‐positive aerobes, S. aureus was found most frequently and 40% were MRSA. MRSA was isolated more commonly in patients treated with antibiotics prior to the swab compared to those who had not received antibiotics (P = 0.01). Patients whose foot ulcers were infected by MRSA had longer healing time than patients whose ulcers were infected by methicillin‐sensitive S. aureus (mean (range) 35.4 (19–64) and 17.8 (8–24) weeks, respectively, P = 0.03). Conclusion MRSA infection is common in diabetic foot ulcers and is associated with previous antibiotic treatment and prolonged time to healing. Further studies are required to assess the need for antibiotics in treating foot ulcers in diabetes and to assess the optimum therapeutic approach to this problem.
doi_str_mv 10.1046/j.1464-5491.1999.00132.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70788870</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70788870</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhi1ERZeWV0A-IG5J7diOY8QFlbZU2sKBQi9I1mTWoV6yydZOxO7b4zSrwpGDZcvz_TPWZ0IoZzlnsjxb51yWMlPS8JwbY3LGuCjy3TOyeCo8JwumZZEJpvkxeRnjOkGFEeYFOeZMcWaUXJAfN2649-jb1ndZcNHHAbqBfh1ge79ve-wRx0hhDG6M7yh01HcYHETf_aTb0Net26QrCnTloXaDR9r0_UAxtfN4So4aaKN7ddhPyLfLi9vzT9nyy9X1-YdlhqooiwwLdAA1ogZUipWVEiCUK2CldClRGAnC8KY0TZXKmldpsULUKy7rUjkUJ-Tt3De96GF0cbAbH9G1LXSuH6PVTFdVpVkCqxnE0McYXGO3wW8g7C1ndjJr13YSaCeBdjJrH83aXYq-PswY641b_ROcVSbgzQGAiNA2ATr08S9nSmWKCXs_Y7996_b_Pd9-vLlIhxTP5nj6KLd7ikP4ZUsttLJ3n6_s5VLoO6O_26X4A2A6o2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70788870</pqid></control><display><type>article</type><title>Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Tentolouris, N. ; Jude, E. B. ; Smirnof, I. ; Knowles, E. A. ; Boulton, A. J. M.</creator><creatorcontrib>Tentolouris, N. ; Jude, E. B. ; Smirnof, I. ; Knowles, E. A. ; Boulton, A. J. M.</creatorcontrib><description>Summary Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin‐resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, selected from an outpatient diabetic foot clinic. Seventy‐five patients (79 ulcers) with positive wound swabs were included. Size of ulcer and time to healing, in particular for MRSA‐infected ulcers, were measured in all patients. Results Gram‐positive aerobic bacteria were the commonest micro‐organism isolated (56.7%) followed by Gram‐negative aerobic bacteria and anaerobes (29.8% and 13.5%, respectively). Of the Gram‐positive aerobes, S. aureus was found most frequently and 40% were MRSA. MRSA was isolated more commonly in patients treated with antibiotics prior to the swab compared to those who had not received antibiotics (P = 0.01). Patients whose foot ulcers were infected by MRSA had longer healing time than patients whose ulcers were infected by methicillin‐sensitive S. aureus (mean (range) 35.4 (19–64) and 17.8 (8–24) weeks, respectively, P = 0.03). Conclusion MRSA infection is common in diabetic foot ulcers and is associated with previous antibiotic treatment and prolonged time to healing. Further studies are required to assess the need for antibiotics in treating foot ulcers in diabetes and to assess the optimum therapeutic approach to this problem.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1046/j.1464-5491.1999.00132.x</identifier><identifier>PMID: 10510954</identifier><identifier>CODEN: DIMEEV</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Aged ; Associated diseases and complications ; Bacterial diseases ; Biological and medical sciences ; diabetes mellitus ; Diabetes Mellitus, Type 1 - microbiology ; Diabetes Mellitus, Type 2 - microbiology ; Diabetes. Impaired glucose tolerance ; Diabetic Foot - drug therapy ; Diabetic Foot - microbiology ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; foot ulceration ; Human bacterial diseases ; Humans ; infections ; Infectious diseases ; Medical sciences ; Methicillin Resistance ; Middle Aged ; MRSA ; Retrospective Studies ; Staphylococcal Infections - drug therapy ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation &amp; purification</subject><ispartof>Diabetic medicine, 1999-09, Vol.16 (9), p.767-771</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3</citedby><cites>FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1965924$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10510954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tentolouris, N.</creatorcontrib><creatorcontrib>Jude, E. B.</creatorcontrib><creatorcontrib>Smirnof, I.</creatorcontrib><creatorcontrib>Knowles, E. A.</creatorcontrib><creatorcontrib>Boulton, A. J. M.</creatorcontrib><title>Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Summary Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin‐resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, selected from an outpatient diabetic foot clinic. Seventy‐five patients (79 ulcers) with positive wound swabs were included. Size of ulcer and time to healing, in particular for MRSA‐infected ulcers, were measured in all patients. Results Gram‐positive aerobic bacteria were the commonest micro‐organism isolated (56.7%) followed by Gram‐negative aerobic bacteria and anaerobes (29.8% and 13.5%, respectively). Of the Gram‐positive aerobes, S. aureus was found most frequently and 40% were MRSA. MRSA was isolated more commonly in patients treated with antibiotics prior to the swab compared to those who had not received antibiotics (P = 0.01). Patients whose foot ulcers were infected by MRSA had longer healing time than patients whose ulcers were infected by methicillin‐sensitive S. aureus (mean (range) 35.4 (19–64) and 17.8 (8–24) weeks, respectively, P = 0.03). Conclusion MRSA infection is common in diabetic foot ulcers and is associated with previous antibiotic treatment and prolonged time to healing. Further studies are required to assess the need for antibiotics in treating foot ulcers in diabetes and to assess the optimum therapeutic approach to this problem.</description><subject>Aged</subject><subject>Associated diseases and complications</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>diabetes mellitus</subject><subject>Diabetes Mellitus, Type 1 - microbiology</subject><subject>Diabetes Mellitus, Type 2 - microbiology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Foot - drug therapy</subject><subject>Diabetic Foot - microbiology</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>foot ulceration</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Middle Aged</subject><subject>MRSA</subject><subject>Retrospective Studies</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqNkcFu1DAQhi1ERZeWV0A-IG5J7diOY8QFlbZU2sKBQi9I1mTWoV6yydZOxO7b4zSrwpGDZcvz_TPWZ0IoZzlnsjxb51yWMlPS8JwbY3LGuCjy3TOyeCo8JwumZZEJpvkxeRnjOkGFEeYFOeZMcWaUXJAfN2649-jb1ndZcNHHAbqBfh1ge79ve-wRx0hhDG6M7yh01HcYHETf_aTb0Net26QrCnTloXaDR9r0_UAxtfN4So4aaKN7ddhPyLfLi9vzT9nyy9X1-YdlhqooiwwLdAA1ogZUipWVEiCUK2CldClRGAnC8KY0TZXKmldpsULUKy7rUjkUJ-Tt3De96GF0cbAbH9G1LXSuH6PVTFdVpVkCqxnE0McYXGO3wW8g7C1ndjJr13YSaCeBdjJrH83aXYq-PswY641b_ROcVSbgzQGAiNA2ATr08S9nSmWKCXs_Y7996_b_Pd9-vLlIhxTP5nj6KLd7ikP4ZUsttLJ3n6_s5VLoO6O_26X4A2A6o2A</recordid><startdate>199909</startdate><enddate>199909</enddate><creator>Tentolouris, N.</creator><creator>Jude, E. B.</creator><creator>Smirnof, I.</creator><creator>Knowles, E. A.</creator><creator>Boulton, A. J. M.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199909</creationdate><title>Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic</title><author>Tentolouris, N. ; Jude, E. B. ; Smirnof, I. ; Knowles, E. A. ; Boulton, A. J. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Aged</topic><topic>Associated diseases and complications</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>diabetes mellitus</topic><topic>Diabetes Mellitus, Type 1 - microbiology</topic><topic>Diabetes Mellitus, Type 2 - microbiology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Foot - drug therapy</topic><topic>Diabetic Foot - microbiology</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>foot ulceration</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Middle Aged</topic><topic>MRSA</topic><topic>Retrospective Studies</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tentolouris, N.</creatorcontrib><creatorcontrib>Jude, E. B.</creatorcontrib><creatorcontrib>Smirnof, I.</creatorcontrib><creatorcontrib>Knowles, E. A.</creatorcontrib><creatorcontrib>Boulton, A. J. M.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tentolouris, N.</au><au>Jude, E. B.</au><au>Smirnof, I.</au><au>Knowles, E. A.</au><au>Boulton, A. J. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>1999-09</date><risdate>1999</risdate><volume>16</volume><issue>9</issue><spage>767</spage><epage>771</epage><pages>767-771</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><coden>DIMEEV</coden><abstract>Summary Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin‐resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, selected from an outpatient diabetic foot clinic. Seventy‐five patients (79 ulcers) with positive wound swabs were included. Size of ulcer and time to healing, in particular for MRSA‐infected ulcers, were measured in all patients. Results Gram‐positive aerobic bacteria were the commonest micro‐organism isolated (56.7%) followed by Gram‐negative aerobic bacteria and anaerobes (29.8% and 13.5%, respectively). Of the Gram‐positive aerobes, S. aureus was found most frequently and 40% were MRSA. MRSA was isolated more commonly in patients treated with antibiotics prior to the swab compared to those who had not received antibiotics (P = 0.01). Patients whose foot ulcers were infected by MRSA had longer healing time than patients whose ulcers were infected by methicillin‐sensitive S. aureus (mean (range) 35.4 (19–64) and 17.8 (8–24) weeks, respectively, P = 0.03). Conclusion MRSA infection is common in diabetic foot ulcers and is associated with previous antibiotic treatment and prolonged time to healing. Further studies are required to assess the need for antibiotics in treating foot ulcers in diabetes and to assess the optimum therapeutic approach to this problem.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10510954</pmid><doi>10.1046/j.1464-5491.1999.00132.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0742-3071
ispartof Diabetic medicine, 1999-09, Vol.16 (9), p.767-771
issn 0742-3071
1464-5491
language eng
recordid cdi_proquest_miscellaneous_70788870
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Associated diseases and complications
Bacterial diseases
Biological and medical sciences
diabetes mellitus
Diabetes Mellitus, Type 1 - microbiology
Diabetes Mellitus, Type 2 - microbiology
Diabetes. Impaired glucose tolerance
Diabetic Foot - drug therapy
Diabetic Foot - microbiology
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
foot ulceration
Human bacterial diseases
Humans
infections
Infectious diseases
Medical sciences
Methicillin Resistance
Middle Aged
MRSA
Retrospective Studies
Staphylococcal Infections - drug therapy
Staphylococcal infections, streptococcal infections, pneumococcal infections
Staphylococcus aureus - drug effects
Staphylococcus aureus - isolation & purification
title Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A22%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methicillin-resistant%20Staphylococcus%20aureus:%20an%20increasing%20problem%20in%20a%20diabetic%20foot%20clinic&rft.jtitle=Diabetic%20medicine&rft.au=Tentolouris,%20N.&rft.date=1999-09&rft.volume=16&rft.issue=9&rft.spage=767&rft.epage=771&rft.pages=767-771&rft.issn=0742-3071&rft.eissn=1464-5491&rft.coden=DIMEEV&rft_id=info:doi/10.1046/j.1464-5491.1999.00132.x&rft_dat=%3Cproquest_cross%3E70788870%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5262-c2ceaabcc7ac5506853a35e2ad5764c394a391f69f8550718071023bd14b65ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70788870&rft_id=info:pmid/10510954&rfr_iscdi=true